Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/1995
03/28/1995CA1334940C Production of glucose oxidase in recombinant systems
03/23/1995WO1995008115A1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
03/23/1995WO1995007992A2 Cloned glutamic acid decarboxylase
03/23/1995WO1995007984A1 Human receptor h4-1bb
03/23/1995WO1995007983A1 Human mu opioid receptor
03/23/1995WO1995007982A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
03/23/1995WO1995007935A1 cDNA ENCODING A NOVEL HUMAN PROTEIN TYROSINE PHOSPHATASE
03/23/1995WO1995007934A2 Il8 inhibitors
03/23/1995WO1995007933A1 Methods and composition for the modulation of host immune response to allergens
03/23/1995WO1995007930A1 Protein for mediating cholesterol absorption and an inhibitor thereof
03/23/1995WO1995007922A1 Drug binding protein
03/23/1995WO1995007907A1 Nucleoside derivatives, methods for the manufacture thereof and specific polyclonal and monoclonal antibodies of said derivatives
03/23/1995WO1995007717A1 Method of inhibiting binding of reticulocytes to endothelium by interfering with vla-4/vcam-1 interactions
03/23/1995WO1995007716A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
03/23/1995WO1995007715A1 Cd8+ cell antiviral factor
03/23/1995WO1995007706A1 The semaphorin gene family
03/23/1995CA2171955A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
03/23/1995CA2171739A1 Human mu opioid receptor
03/23/1995CA2171610A1 Cdna encoding a novel human protein tyrosine phosphatase
03/23/1995CA2170405A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
03/22/1995EP0644262A2 Gene coding for a protein regulating aureobasidin sensitivity
03/22/1995EP0644202A1 Synthetic antigens for the detection of antibodies to hepatitis C virus
03/22/1995EP0643974A1 Vaccine against lyme disease
03/22/1995EP0643835A1 Htlv-i/htlv-ii assay and method
03/22/1995EP0643767A1 Osteogenic peptides
03/22/1995EP0643728A1 Icam-related protein
03/22/1995EP0643719A1 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
03/22/1995EP0643586A1 Compositions useful in diagnosis and prophylaxis of lyme disease
03/22/1995EP0449958B1 Meningococcal class 1 outer-membrane protein vaccine
03/22/1995EP0386136B1 Enzyme immunoassay for detecting hiv antigens in human sera
03/22/1995EP0299050B1 Isolation of single chain proteins with fsh suppressing activity from follicular fluid
03/22/1995CN1100428A Improved meningococcal polysaccharide conjugate vaccine
03/22/1995CN1100426A Lysosomal enzyme-cleavable antitumor drug conjugates
03/21/1995US5399560 1,2,4-triazine products resulting from the inhibition of advanced glycosylation
03/21/1995US5399485 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis caused by Rochalimaea henselae
03/21/1995US5399481 Methods and compositions for diagnosing chronic immune thrombocytopenic purpura
03/16/1995WO1995007467A1 Assay systems using the cntf signal transduction pathway
03/16/1995WO1995007466A2 Biotin-analog conjugated antibodies for positive cell selection and release
03/16/1995WO1995007354A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
03/16/1995WO1995007351A1 Intron-mediated recombinant techniques and reagents
03/16/1995WO1995007348A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
03/16/1995WO1995007301A1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders
03/16/1995WO1995007298A1 Natural rubber latex antigens associated with allergies
03/16/1995WO1995007290A1 Method for purifying egg yolk immunoglobulins
03/16/1995WO1995007102A1 A method of promoting cellular function
03/16/1995WO1995007096A1 Treatment of autoimmune disease
03/16/1995WO1995007087A1 Sulfamethoxazole-specific immunosuppressive agents
03/16/1995WO1995007020A1 EXPRESSION OF THE DEVELOPMENTAL I ANTIGEN BY A CLONED HUMAN cDNA ENCODING A BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE
03/16/1995WO1995003415A3 Epstein-barr virus dna sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests
03/16/1995WO1995000643A3 Human cell adhesion protein aamp-1 and uses thereof
03/16/1995WO1994026886A3 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable
03/16/1995CA2171115A1 Sulfamethoxazole-specific immunosuppressive agents
03/16/1995CA2171112A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
03/16/1995CA2168205A1 Biotin-analog conjugated antibodies for positive cell selection and release
03/15/1995EP0643077A1 Monoclonal antibody against B70 molecule
03/15/1995EP0642668A1 Nuclear matrix protein fluid assay
03/15/1995EP0642666A1 Hepatitis c assay
03/15/1995EP0642664A1 Assays for o?6 -methylguanine-dna methyltransferase
03/15/1995EP0642585A1 Activation of oligomerizing receptors by using fused receptor ligands
03/15/1995EP0642584A1 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors
03/15/1995EP0642581A1 Clostridium perfringens vaccines
03/15/1995EP0642577A1 Antibodies with specificity for multiple adhesion molecules
03/15/1995EP0642532A1 Proteinoid carriers and methods for preparation and use thereof
03/15/1995EP0642507A1 Catalytic antibodies against cocaine and methods of using and producing same
03/15/1995EP0642356A1 Antibodies to p-selectin and their uses
03/15/1995EP0642354A1 METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R
03/15/1995EP0642348A1 Antibiotic cryptdin peptides and methods of their use
03/15/1995EP0435890B1 Renal tubule function test
03/15/1995EP0414741B1 Further improvements relating to drug delivery systems
03/14/1995US5397712 In a living person, imunoassay using cerebrospinal fluid and a monoclonal antibody from a hybridoma ATCC HB11079
03/14/1995US5397703 Method for generation of antibodies to cell surface molecules
03/14/1995US5397696 Papua New Guinea human T-lymphotropic virus
03/14/1995US5397569 Method of treating Infectious Bursal Disease Virus infections
03/14/1995US5397568 Method of treating infectious bursal disease virus infections
03/14/1995US5397562 Administering fluorocarbon emulsions, determination of oxygen tension, diagnosis of tumors based on degree of hypoxia
03/09/1995WO1995006748A1 Monoclonal antibody that induces apoptosis
03/09/1995WO1995006747A1 Monoclonal antibody that recognizes interstitial cell surface antigen
03/09/1995WO1995006735A2 Nucleotide sequences for novel protein tyrosine phosphatases
03/09/1995WO1995006734A1 Cloning of a member of the serine-threonine-kinase family
03/09/1995WO1995006732A2 Bacterial exported proteins and acellular vaccines based thereon
03/09/1995WO1995006729A1 Differentially expressed leishmania genes and proteins
03/09/1995WO1995006728A2 T cell epitopes of ryegrass pollen allergen
03/09/1995WO1995006725A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen
03/09/1995WO1995006724A1 Vip2 (vasoactive intestinal polypeptide) receptor
03/09/1995WO1995006719A1 Method for specific immunoassay of human plasmatic glutathione peroxidase
03/09/1995WO1995006666A1 Anti-gp39 antibodies and uses therefor
03/09/1995WO1995006665A1 Compositions and methods for targeting cells and modulating pulmonary surfactant secretion
03/09/1995WO1995006664A1 Dna encoding prostaglandin receptor ep2
03/09/1995WO1995006662A1 Neuron regulatory factor for promoting neuron survival
03/09/1995WO1995006660A1 Epiligrin, an epithelial ligand for integrins
03/09/1995WO1995006657A1 Interleukin-10 and immunosuppression
03/09/1995WO1995006484A1 Lipopeptide compounds
03/09/1995WO1995006481A1 Methods for inducing antigen-specific t cell tolerance
03/09/1995WO1995006480A1 Methods of prolonged suppression of humoral immunity
03/09/1995WO1995006478A1 RECOMBINANT COFFEE BEAN α-GALACTOSIDASE
03/09/1995WO1995006415A1 Senescent cell-derived inhibitors of dna synthesis
03/09/1995WO1995006407A1 Novel component of amyloid in alzheimer's disease and methods for use of same
03/09/1995WO1994029457A3 Process for producing fusion proteins comprising scfv fragments by a transformed mould
03/09/1995DE4419399C1 Process for the preparation of heterologous bispecific antibodies
03/09/1995DE4329004A1 Monoclonal antibodies against the Thomsen-Friedenreich antigen, their preparation and their use for tumour detection
1 ... 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 ... 1494